Suicide Prevention for Sexual and Gender Minority Youth (Open Trial)

N/A

Waitlist Available

Led By Aaron Blashill, Ph.D.

Research Sponsored by San Diego State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

1) age 15 to 29 years; 2) identifies as gay, lesbian, bisexual, transgender, genderqueer, asexual, pansexual, non-binary, or another non-exclusively heterosexual identity, and/or reports same-gender romantic attraction, and/or reports same-gender sexual behavior in the past 12 months; 3) resides in San Diego County, California; 4) speaks English; 5) is willing and able to provide informed consent; 6) reports suicidal ideation over the past two weeks, as indicated by the clinician-administered Columbia-Suicide Severity Rating Scale (C-SSRS) Baseline version; and 7) reports a lifetime history of one or more suicide attempts.

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline suicide-related external coping scores at 3 and 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to test a support program for young people from sexual and gender minority groups who are at high risk of suicide. The program combines safety planning with ongoing guidance to help participants feel more connected and teach them how to cope with suicidal thoughts. Attachment-based family therapy (ABFT) has been adapted to address the needs of transgender and gender diverse youth experiencing suicidal thoughts and behavior.

Eligible Conditions

Self-Harm
Suicide

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline thwarted belongingness scores at 3 and 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline thwarted belongingness scores at 3 and 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline thwarted belongingness scores at 3 and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Suicide-Related Coping Scale (SRCS) - External Coping Skills

Suicide-Related Coping Scale (SRCS) - Internal Coping Skills

The Interpersonal Needs Questionnaire-15 (INQ-15) - Thwarted Belongingness

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Safety Planning Intervention with Navigation ServicesExperimental Treatment1 Intervention

A patient navigation (PN) intervention for SGM youth/emerging adults designed to target mechanisms (i.e., decreasing thwarted belongingness and increasing suicide-related coping skills) that theoretically underlie suicide. The proposed intervention will integrate a single-session, empirically supported, suicide prevention intervention (Safety Planning Intervention; SPI) with PN services (PN+SPI). The patient navigator will deliver the SPI and continue frequent contact for the purpose of providing motivational enhancement, problem-solving, reinforcing coping strategies, and connecting participants to social support and mental health resources (e.g., SGM-specific support groups within the community).

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Safety Planning Intervention with Navigation Services

2021

N/A

~40

0 / 1Eligibility criteria met